Genetic factors in atherosclerosis: status and perspectives
University Magna Graecia, Catanzaro, Italy
* Correspondence: Ciro Indolfi, MD, Division of Cardiology, University Magna Graecia, Catanzaro, Italy.
Abstract
Genes contribute to both the cause and the pathogenesis of virtually all abnormalities of human physiology and behaviour, including, of course, atherosclerosis. A variety of genetic factors, in addition to well studied errors of lipid metabolism, clearly predispose to atherosclerosis. Few genes apart other than those involved in lipid metabolism have such an over-whelming impact that they may be identified on the basis of family history. However, genes that predispose to hypertension and diabetes mellitus; control arterial diameter, reactivity and branching angles; affect platelet adhesiveness, thrombosis and fibrinolysis; and regulate endothelial and smooth muscle function can all be considered candidate genes for study in families predisposed to atherosclerosis.
Key Words: Atherosclerosis • genes • polymorphisms
References
- Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409:860–921[CrossRef][Medline]
- Chakravarti A. To a future of genetic medicine. Nature. 2001;409:822–823[CrossRef][Medline]
- Norum RA, Lakier JB, Goldstein S, et al. Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease. N Engl J Med. 1982;306:1513–1519[Abstract]
- Karathanasis SK, Ferris E, Haddad IA. DNA inversion within the apolipoproteins AI/CIH/AIV encoding gene cluster of certain patients with premature atherosclerosis. Proc Natl Acad Sci USA. 1987;84:7198–7202
[Abstract/Free Full Text] - Indolfi C, Esposito G, Di Lorenzo E, et al. Smooth muscle cell proliferation is proportional to the degree of balloon injury in a rat model of restenosis. Circulation. 1995;92:1230–1235
[Abstract/Free Full Text] - Indolfi C, Avvedimento EV, Rapacciuolo A, et al. Inhibition of cellular RAS prevents smooth muscle cell proliferation after vascular injury in vivo. Nat Med. 1995;6:541–545
- Indolfi C, Chiariello M, Avvedimento EV. Selective gene therapy of proliferative disorders: sense and antisense. Nat Med. 1996;6:634–635
- Indolfi C, Avvedimento EV, Rapacciuolo, et al. In vivo gene transfer: prevention of neointima formation by inhibition of mitogen-activated protein kinase. Basic Res Cardiol. 1997;92:378–384[Web of Science][Medline]
- Indolfi C, Avvedimento EV, Di Lorenzo E, et al. Activation of cAMP-PKA signalling in vivo inhibits mooth muscle cell proliferation induced by vascular injury. Nat Med. 1997;3:775–779[CrossRef][Web of Science][Medline]
- Indolfi C, Coppola C, Torella D, Chiariello M. Gene therapy for restenosis after balloon angioplasty and stenting. Cardiol Rev. 1999;7:324–331[Medline]
- Indolfi C, Di Lorenzo E, Rapacciuolo A, et al. 8-Chloro-cAMP inhibits smooth muscle cell poliferation in vitro and neointimal formation induced by balloon injury in vivo. J Am Coll Cardiol. 2000;36:288–293
[Abstract/Free Full Text] - Indolfi C, Stabile E, Coppola C, et al. Membrane-bound protein kinase A inhibits smooth muscle cell proliferation in vitro and in vivo by amplifying cAMP-protein kinase A signals. Circ Res. 2001;88:319–324
[Abstract/Free Full Text] - Indolfi C, Torella D, Cavuto L, et al. Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats. Circulation. 2001;103:2980–2986
[Abstract/Free Full Text]
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||